J Pazdur

Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Edward Keystone, Mark C. Genovese, Lars Klareskog et al. · Annals of the Rheumatic Diseases · 2008 · 541 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti–tumor necrosis factor α treatment

Maria Ziółkowska, Anna Radzikowska, Grazyna Luszczykiewicz et al. · Arthritis & Rheumatism · 2002 · 200 citations

Life Sciences, Immunology, Orthopedic Surgery +17

Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study

Edward Keystone, Mark C. Genovese, Lars Klareskog et al. · Annals of the Rheumatic Diseases · 2010 · 143 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes

Waldemar L. Olszewski, J Pazdur, E Kubasiewicz et al. · Arthritis & Rheumatism · 2001 · 97 citations

Medicine, Clinical Sciences, Immunology +17

The effect of methylprednisolone on proliferation of PBMCs obtained from steroid‐sensitive and steroid‐resistant rheumatoid arthritis patients

J Pazdur, Janusz Jaworski, E. Kaminska‐Tchorzewska et al. · Scandinavian Journal of Rheumatology · 2007 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +17